Allianz Asset Management GmbH Has $2.06 Million Stake in Omega Healthcare Investors, Inc. $OHI

Allianz Asset Management GmbH decreased its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 17.2% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 56,325 shares of the real estate investment trust’s stock after selling 11,662 shares during the quarter. Allianz Asset Management GmbH’s holdings in Omega Healthcare Investors were worth $2,064,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of OHI. GAMMA Investing LLC grew its position in shares of Omega Healthcare Investors by 14.2% during the 1st quarter. GAMMA Investing LLC now owns 4,572 shares of the real estate investment trust’s stock worth $174,000 after buying an additional 568 shares during the period. Janney Montgomery Scott LLC grew its position in Omega Healthcare Investors by 5.0% in the 1st quarter. Janney Montgomery Scott LLC now owns 34,453 shares of the real estate investment trust’s stock valued at $1,312,000 after purchasing an additional 1,651 shares during the period. Oppenheimer Asset Management Inc. grew its position in Omega Healthcare Investors by 17.2% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 31,736 shares of the real estate investment trust’s stock valued at $1,209,000 after purchasing an additional 4,669 shares during the period. International Assets Investment Management LLC acquired a new stake in Omega Healthcare Investors in the 1st quarter valued at $394,000. Finally, Cornerstone Enterprises LLC grew its position in Omega Healthcare Investors by 6.0% in the 1st quarter. Cornerstone Enterprises LLC now owns 135,830 shares of the real estate investment trust’s stock valued at $5,172,000 after purchasing an additional 7,652 shares during the period. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

OHI opened at $40.48 on Friday. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10. The company has a market capitalization of $11.94 billion, a price-to-earnings ratio of 24.99, a P/E/G ratio of 1.90 and a beta of 0.70. The firm’s fifty day moving average price is $41.59 and its two-hundred day moving average price is $39.00. Omega Healthcare Investors, Inc. has a 1 year low of $35.04 and a 1 year high of $44.42.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.32. The firm had revenue of $235.60 million for the quarter, compared to the consensus estimate of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The business’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently issued reports on OHI shares. Mizuho lifted their price target on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a research report on Thursday, September 11th. Raymond James Financial reissued an “outperform” rating on shares of Omega Healthcare Investors in a research report on Tuesday, September 2nd. Cantor Fitzgerald started coverage on shares of Omega Healthcare Investors in a research report on Wednesday, October 1st. They issued an “overweight” rating and a $50.00 price target for the company. Scotiabank lifted their price target on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a research report on Thursday, August 28th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Omega Healthcare Investors in a research report on Wednesday, October 8th. Six investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Omega Healthcare Investors currently has a consensus rating of “Moderate Buy” and a consensus target price of $44.50.

Insider Transactions at Omega Healthcare Investors

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the transaction, the director directly owned 18,654 shares of the company’s stock, valued at $749,144.64. The trade was a 11.82% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.50% of the stock is owned by corporate insiders.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.